Ketamine Hydrochloride Injection
Product Images NDC 65219-184

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Ketamine Hydrochloride (NDC 65219-184). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ket0p 0005 01)

Chemical Structure (Ket0p 0005 01)
Chemical structure diagram of ketamine hydrochloride showing its molecular framework including a cyclohexanone ring bonded to an aromatic phenyl ring with a chlorine substitution, a methylamino group, and an associated hydrochloride component.*
FDA Label Image

Logo (Ket0p 0005 02)

FDA Label Image

Package Label (PRINCIPAL DISPLAY – Ketamine HCl Injection, USP 20 mL Vial Label)

Package Label (PRINCIPAL DISPLAY – Ketamine HCl Injection, USP 20 mL Vial Label)
The label for Ketamine HCl Injection, USP 200 mg/20 mL (10 mg/mL) multiple-dose vial by Fresenius Kabi USA, LLC. It indicates use for slow intravenous or intramuscular administration and includes dosage, storage, and ingredient information. The label features the NDC 65219-184-01 and a barcode.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY – Ketamine HCl Injection, USP 20 mL Tray Label)

Package Label (PRINCIPAL DISPLAY – Ketamine HCl Injection, USP 20 mL Tray Label)
Ketamine HCl Injection, USP 200 mg/20 mL (10 mg/mL) vial label. The product is for slow intravenous or intramuscular use, supplied in 20 mL multiple-dose vials. It is manufactured by Fresenius Kabi USA, LLC in Lake Zurich, Illinois. The label includes dosage information and storage instructions, along with warnings about color variation and preservative content.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY – Ketamine HCl Injection, USP 10 mL Vial Label)

Package Label (PRINCIPAL DISPLAY – Ketamine HCl Injection, USP 10 mL Vial Label)
Label for Ketamine HCl Injection, USP 50 mg/mL, 10 mL multiple-dose vial. The label states the strength as 500 mg per 10 mL and indicates use for slow intravenous or intramuscular injection. Manufactured by Fresenius Kabi USA, LLC, Lake Zurich, IL. Includes NDC 65219-188-01 and storage instructions to protect from light.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY – Ketamine HCl Injection, USP 10 mL Tray Label)

Package Label (PRINCIPAL DISPLAY – Ketamine HCl Injection, USP 10 mL Tray Label)
Label for ketamine hydrochloride injection USP, 50 mg/mL strength (500 mg/10 mL vial). Intended for slow intravenous or intramuscular use, the package contains 10 mL x 10 multiple-dose vials. Manufactured by Fresenius Kabi USA, LLC, with storage and usage instructions detailed on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.